You have 9 free searches left this month | for more free features.

targeted therapies

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Specific Genetic Tests and Efficacy of Targeted Therapies in

Recruiting
  • Non-small Cell Lung Cancer
    • Changsha, Hunan, China
      Hunan Cancer hospital
    Dec 26, 2022

    Developing Novel Microbiota-Targeted Therapies for Irritable

    Completed
    • Irritable Bowel Syndrome
      • Rochester, Minnesota
        Mayo Clinic
      Aug 15, 2022

      Cancer Trial in Lexington (Therapeutic Intervention)

      Recruiting
      • Cancer
      • Therapeutic Intervention
      • Lexington, Kentucky
        Markey Cancer Center, University of Kentucky
      Nov 18, 2022

      Kinase Inhibitor Targeted Therapies

      Not yet recruiting
      • Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib
      • Measurement of drug concentrations
      • Rennes, France
      • +2 more
      Nov 7, 2022

      Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

      Active, not recruiting
      • Prostate Cancer
      • Abiraterone Acetate
      • +3 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Dec 6, 2022

      Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

      Active, not recruiting
      • Renal Cell Carcinoma
      • Perfusion CT scan
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Dec 6, 2022

      Lung Cancer, EGFR Gene Mutation, EGFR Trial in Charlottesville (Sensus Smartwatch Application, RX Cap, Fitbit Sense)

      Recruiting
      • Lung Cancer
      • +3 more
      • Sensus Smartwatch Application
      • +3 more
      • Charlottesville, Virginia
        University of Virginia
      Aug 26, 2022

      Inflammatory Disease, Autoimmune Diseases Trial in Paris (Kineret, Humira, Stelara)

      Recruiting
      • Inflammatory Disease
      • Autoimmune Diseases
      • Paris, France
        Hôpital Cochin
      Oct 10, 2022

      Moderate to Severe Ulcerative Colitis Patients Treated With

      Recruiting
      • Ulcerative Colitis
      • Inflammatory Bowel Diseases
      • Procedure: endoscopic biopsy
      • +2 more
      • Nancy, Lorraine, France
        Central Hospital
      Jul 11, 2022

      Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

      Not yet recruiting
      • Slow-Flow Vascular Malformation
      • +17 more
      • Parkville, Victoria, Australia
        The Royal Children's Hospital
      Aug 7, 2023

      PET/CT Characterization of Treatment Resistance

      Recruiting
      • Prostate Cancer
      • F-fluorodeoxyglucose positron emission tomography (FDG PET)
      • prostate-specific membrane antigen positron emission tomography (PSMA PET)
      • Madison, Wisconsin
        University of Wisconsin
      Jan 24, 2023

      HER2-HER3 Dimer in Tumour and Blood Samples From HER2 Positive

      Recruiting
      • HER2-positive Breast Cancer
      • Acquisition of blood samples and tumour tissue samples (biopsies)
      • Brighton, United Kingdom
      • +1 more
      Nov 9, 2022

      Targeted Therapies in BRAF Positive Metastatic Melanoma in US

      Active, not recruiting
      • Melanoma
      • New York, New York
        Pfizer Investigational Site
      Feb 18, 2022

      Chronic Myeloid Leukemia Trial in Saint-Étienne (Pharmaceutical intervention)

      Recruiting
      • Chronic Myeloid Leukemia
      • Pharmaceutical intervention
      • Saint-Étienne, France
        CHU de Saint-Etienne
      Feb 24, 2022

      Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon Trial in United States (afatinib,

      Completed
      • Non-small Cell Lung Carcinoma
      • +3 more
      • Denver, Colorado
      • +7 more
      Aug 17, 2022

      CLL, Chronic Lymphocytic Leukemia Trial in Milano, Torino (Peripheral blood samples withdrawal)

      Recruiting
      • CLL
      • Chronic Lymphocytic Leukemia
      • Peripheral blood samples withdrawal
      • Milano, Italy
      • +1 more
      Jan 3, 2022

      Metastatic Renal Cell Carcinoma Trial in Lyon (denosumab)

      Terminated
      • Metastatic Renal Cell Carcinoma
      • Lyon, France
        Centre Leon Berard
      Oct 14, 2021

      Patterns With Targeted Therapies In Mrcc In Sweden - A

      Completed
      • Kidney Neoplasms
      • Sollentuna, Sweden
        Pfizer Innovations AB
      Sep 8, 2021

      Gastric Cancer Trial in Craiova (Endoscopic ultrasound)

      Recruiting
      • Gastric Cancer
      • Endoscopic ultrasound
      • Craiova, Romania
        Research Center in Gastroenterology and Hepatology, University o
      Sep 24, 2021

      Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)

      Not yet recruiting
      • Recurrent Multiple Myeloma
      • Refractory Multiple Myeloma
      • Biospecimen Collection
      • +9 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Aug 1, 2023

      Breast Cancer, Solid Tumor Trial in Worldwide (Inavolisib, Fulvestrant, Letrozole)

      Recruiting
      • Breast Cancer
      • Solid Tumor
      • Boston, Massachusetts
      • +12 more
      Jan 10, 2023

      Oncology Research Information Exchange Network Lung Cancer Study

      Active, not recruiting
      • Lung Cancer
      • Non-small Cell Lung Cancer
      • No Intervention
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Sep 30, 2022

      Severe Toxicity of Targeted Therapies in Elderly Cancer

      Completed
      • Cancer
      • Blood sample
      • Bordeaux, France
      • +1 more
      Jun 3, 2021

      Multi-layer Data to Improve Diagnosis, Predict Therapy

      Recruiting
      • High Grade Ovarian Serous Adenocarcinoma
      • WGS and RNA sequencing
      • +2 more
      • Turku, Finland
        Turku University Hospital
      Apr 26, 2022

      Rare Malignant Tumor Trial in Chuo-ku

      Recruiting
      • Rare Malignant Neoplasm
        • Chuo-ku, Tokyo, Japan
          National Cancer Center Hospital, Japan
        Jan 19, 2022